Dr. Joseph Wendolowski at Delaware Total Foot and Ankle Center recently announced that he is now offering radial shockwave therapy in his Lewes office.
The enPuls Pro system is a cutting-edge, noninvasive, non-pharmacological, highly effective solution for the treatment of chronic foot, heel and ankle pain as well as soft tissue pain and sports injuries.
Radial shockwave therapy is an FDA-cleared technology proven to increase the rate of healing for soft tissue tendinopathy. This treatment method enhances blood circulation and accelerates the healing process, causing damaged tissue to gradually regenerate.
When a person experiences chronic pain, the body no longer recognizes that there is an injury to that area. As a result, it shuts down the healing process and the person feels no relief.
The ballistic sound waves of the enPuls Pro system penetrate deep through soft tissue, causing a microtrauma or new inflammatory condition to the treated area. Once this occurs, it triggers the body's natural healing response again. The energy emitted also causes the cells in the soft tissue to release certain biochemicals that intensify the body's natural healing process and allow for an array of new microscopic blood vessels to build in the soft tissue.
Radial shockwave therapy has a proven success rate equal to or greater than that of traditional treatment methods including surgery, without the risks, complications and lengthy recovery periods. There are no incisions and no risk of infection or scar tissue. There is no need for anesthesia to be administered during the treatment, as opposed to high-energy shockwave therapy. Patients may be active immediately and resume their normal routine the same day. Many patients find significant and immediate reduction in their pain. Some patients will feel results gradually after ongoing treatments.
Wendolowski provides treatment in his office, and it takes approximately five minutes for each treatment. This technology has been used for more than 20 years and produces about an 80 percent success rate.
For more information, go to www.DTFAC.com.